Why We Start With Sites
A lot of clinical research software is selected by people who are not doing the day-to-day work at the site. They're not the ones handling queries, entering data, or trying to keep visits, documentation, and patient care moving at the same time.
We start with the site because that is where workflow problems show up most clearly. Coordinators feel every extra click, every broken handoff, and every delay. When a tool helps them move faster and keep records accurate, that improvement carries through the study.
That is also why we work directly with sites. We want Gleam to be a product a team chooses because it helps in real use, not just because it sounds good in a buying process. That sets a clear standard for us. The product has to prove itself in the work.
That approach also helps sponsors. Better data, entered more cleanly and with less delay, benefits everyone involved in the study. We just believe the right place to begin is with the people doing the work firsthand.
Building this way keeps us accountable. Feedback comes quickly, and problems are hard to miss. The product gets better in the places that matter because the people using it every day are the ones shaping it.
We think that is the right place to start in clinical research: with the teams carrying the workload. Build for their workflow first, and the rest of the study benefits too.







